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The NF-KB/Rel family of at least five transcription factor polypeptides is thought to function both as a
developmental regulator in B cells and as a rapid response system in all cells. To examine this notion in more
detail, we determined the protein contents of both the inducible and constitutive NF-KB/Rel activities in a
pre-B-cell line, 70Z/3, and a mature B-cell line, WEHI 231. NF-KB p50/p65 is the major inducible nuclear
complex after lipopolysaccharide or phorbol myristate acetate treatment of 70Z/3 cells. The constitutive and
inducible complexes in WEHI 231 cells are mainly composed of p50 and Rel. The constitutive or induced
activities are all sensitive to IKB-a, but this inhibitor is very short-lived in WEHI 231 cells, suggesting that the
balance between synthesis and degradation of IKB-a determines whether a particular cell lineage has
constitutive activity. A patterned expression of the NF-KB/Rel activator proteins emerges from an analysis of
other B-lineage cell lines and splenic B cells: mainly p50 and p65 in pre-B (and non-B) cells, a predominance
of Rel and p50 in mature B cells, and expression of p52 and RelB in plasmacytoma lines. This ordered pattern
of regulators may reflect the requirement for expression of different genes during terminal B-cell differentiation
because different combinations of NF-cB/Rel family members preferentially activate distinct KB sites in reporter
constructs.
B-cell differentiation is an ordered process culminating in
expression of rearranged immunoglobulin (Ig) heavy (H)- and
light (L)-chain gene products (7). Pre-B cells express ,u IgH
protein in their cytoplasm, while the transition from the pre-B
to B stage is accompanied by the rearrangement and expres-
sion of the K L-chain gene. Thus, the regulation of IgK gene
expression is considered a crucial element in B-cell differenti-
ation. The K L-chain intronic enhancer contains several tran-
scription factor binding sites, including a KB site and three E
boxes, that contribute to enhancer activity both in vitro and in
vivo (42). Integrity of the KB site is necessary for any enhancer
activity to be manifest: it is bound by the NF-KB protein (24,
41). Among B-lineage cell lines, the presence of nuclear
NF-KB activity correlates with K gene expression (42). One of
the most useful cell lines has been 70Z/3, which contains a
functionally rearranged but transcriptionally inactive IgK locus
(35). Stimulation of 70Z/3 cells with the B-cell mitogen lipo-
polysaccharide (LPS) causes nuclear translocation of NF-KB
and concomitant K L-chain transcription, followed by surface
expression of an assembled lgM (33). By analogy, the consti-
tutive NF-KB activity in mature B cells has been thought to
play a role in the regulation of IgK gene expression and B-cell
differentiation.
NF-KB is actually present in the cytoplasm of most cells as an
inactive complex with an inhibitor protein, IKB (3). From the
inactive NF-KB/IKB complex, DNA binding NF-KB can be
released by stimulating cells with various exogenous agents
(15). For example, NF-KB is activated in B cells by LPS,
phorbol myristate acetate (PMA), or cross-linking of surface
IgM. In T cells, NF-KB responds to a variety of activating
stimuli, such as PMA, phytohemagglutinin, interleukin-2 (IL-
2), and cross-linking of surface CD3, CD28, and T-cell recep-
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tors. The signal transduction pathways leading to the activation
of NF-KB by these stimuli Pre yet to be identified. Approxi-
mately 10-bp KB sites for NF-KB have been found in the
promoters/enhancers of many cellular and viral genes. These
putative target genes of NF-KB, including IgK, cytokines,
cytokine receptors, and Myc, are involved in the regulation of
the acute-phase response, inflammation, lymphocyte activa-
tion, and cell growth or differentiation. Deregulation or muta-
tion of some NF-KB/Rel and IKB family members has been
associated with tumorigenesis (14).
Both NF-KB and IKB are multigene families (4, 26). The
mammalian NF-KB/Rel family members identified so far in-
clude NFKB-1 (p5O and its precursor, p105), NFKB-2 (p52 and
its precursor, plOO), p65 (RelA), c-Rel (Rel), and RelB. The
approximately 300-amino-acid Rel homology domain shared
by this family mediates DNA binding, dimerization, and inter-
action with lKB. With few exceptions, members of the NF-KB/
Rel family can form heterodimers with other members. The
IKB family of proteins includes IKB-a (MAD-3, pp4O), IKB-P,
IKB-y, and Bcl-3. Prominent within these 1KB-related proteins
are multiple repeated sequences of 33 amino acids, termed
ankyrin repeats, which appear to be responsible for interaction
with the Rel domain.
Although NF-KB p5O/p65 was identified as a nearly ubiqui-
tous cytoplasmic factor, many members of the NF-KB/Rel and
IKB families are inducible genes. In many cell types, NFKB-1,
NFKB-2, c-Rel, RelB, IKB-a, and Bcl-3 are induced in re-
sponse to those stimuli that activate NF-KB/Rel activity (6, 16,
17, 30, 32, 38). Rel is constitutively made in lymphoid cells; its
expression is also inducible (16). Overexpression of Rel leads
to tumorigenesis or programmed cell death (1). Certain mem-
bers of the NF-KB/Rel and IKB families, such as p105 and
c-Rel, are under autoregulation presumably due to the pres-
ence of KB sites in their promoters. The autoregulation of
IKB-a by p65 implies that it too is under NF-KB regulation (40,
44).
Except for mature B cells, most uninduced cells lack nuclear
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NF-KB/Rel binding activity. Nuclear KBF-1 (a p50 ho-
modimer) and p52 homodimers have been detected in un-
stimulated T cells and macrophages by using oligonucleotide
probes containing the IL-2 or IL-2 receptor (IL-2R) KB sites to
which the homodimers bind especially well (21, 22). It was
recently reported that crude spleen B-cell extracts express p50
and RelB in constitutive complexes (25).
As a step toward understanding the physiological role of
NF-KB in IgK gene regulation, B-cell proliferation, and differ-
entiation, we have characterized the nature and regulation of
the constitutive NF-KB activity in B-lineage cells. Our results
demonstrate that the various NF-KB/Rel complexes are differ-
entially expressed in B-lineage cell types. Furthermore, differ-
ent NF-KB/Rel complexes have distinct target gene specifici-
ties.
MATERIALS AND METHODS
Cell lines and tissue culture conditions. All B-lineage cells
were maintained in RPMI 1640 containing 10% defined fetal
calf serum (HyClone), penicillin-streptomycin, and 50 mM
3-mercaptoethanol. Cells were split regularly at a dilution of
1:10 or 1:15. 3T3 cells were cultured in Dulbecco modified
Eagle medium with 10% bovine serum.
Stimulation conditions for cells were the following: cyclo-
heximide (10 ,ug/ml) added 30 min before the addition of other
stimuli; LPS (Sigma L2880; 10 ,ug/ml) for the indicated time;
PMA (100 nM) for 4 h; and tumor necrosis factor alpha
(TNF-ao; Genzyme; 20 ng/ml) for 2 h. For cross-linking surface
IgM on B cells, goat anti-mouse IgM F(ab')2 (Jackson Immu-
noResearch) was added at a concentration of 30 ,ug/ml for 4 h.
For phosphopeptide analysis, cells were treated with PMA for
10 min.
Purification of resting splenic B cells. Erythrocytes were
removed from single-cell splenocyte populations by ammo-
nium chloride lysis. Crude spleen extracts were prepared from
these cells. Resting B cells were purified from these crude
spleen populations by one round of complement lysis with a
Thy 1.2 antibody to remove T cells. The remaining cells were
then fractionated through Percoll gradients (8) to isolate small
resting B cells, contained between 66 and 70% Percoll. These
cells were collected, washed extensively, and incubated in
medium for stimulation with anti-IgM or LPS.
Electrophoretic mobility shift assay (EMSA) and antibody
inhibition. The nuclear and cytosolic fractionation procedure
was slightly modified from the basic protocol of Dignam et al.
(9). Cells were harvested, washed once with phosphate-buff-
ered saline and resuspended into buffer A (10 mM N-2-
hydroxyethylpiperazine-N'-2-sulfonic acid [HEPES; pH 7.9],
1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol) plus 0.1%
Nonidet P-40 (NP-40). Cells were lysed on ice for 2 min and
checked for complete lysis under a microscope. Nuclei were
spun down, and the supernatant was saved as the cytosolic
fraction. The nuclear pellet was resuspended in buffer C (20
mM HEPES [pH 7.9], 25% glycerol, 0.42 M NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride,
0.5 mM dithiothreitol), sonicated for a few seconds to decrease
viscosity, and rotated in the cold room for 30 min. Ultracen-
trifugation was performed to remove insoluble debris. The
supernatant was nuclear extract.
The EMSA was performed as described previously (41). For
antibody inhibition experiments, antibody was purified by
ammonium sulfate precipitation of crude immune serum. The
optimal amount of antibody used in EMSA inhibitions was
determined by using purified proteins. For a 20-,u DNA
binding reaction, 5 ,ug of purified antibody was added per
reaction. Antibody was incubated with a mixture of nuclear
extract and poly (dI-dC) in iX DNA binding buffer (41) on ice
for 30 min before the addition of 32P-labeled KB probe. The
reaction was continued for 15 min at room temperature, and
the mixture was loaded onto a 5% native polyacrylamide gel.
For high-resolution electrophoresis, gels were prerun at 160 V
for 2.5 h, continuing for 3 to 3.5 h after the samples were
loaded.
Immunoprecipitation and pulse-chase experiments. Cells
were harvested, washed, and incubated in RPMI medium
without either methionine or phosphate for 40 min prior to
labeling for 2 h in the presence of 0.5 to 2 mCi of [35]methi-
onine or 32p; per ml at a cell density of 10 x 106/ml. For
pulse-chase experiments, aliquots of [35S]methionine-labeled
cells were chased with cold medium and harvested at 0, 10, 20,
40, 60, 120, 300, and 960 min. Cells were lysed in 1 ml of NP-40
buffer (0.1% NP-40, 250 mM NaCl, 50 mM Tris, 1 mM EDTA)
for coimmunoprecipitation experiments or in radioimmuno-
precipitation assay (RIPA) buffer (25 mM Tris [pH 7.4], 75
mM NaCl, 0.5% Triton X-100, 0.5% sodium deoxycholate
[DOC], 0.01% sodium dodecyl sulfate [SDS], 2.5 mM EDTA)
for phosphopeptide analyses. These buffers contained mixtures
of protease and phosphatase inhibitors (100 ,uM NaVO4, 50
mM NaF, 10 mM sodium pyrophosphate, and 1 mM aprotinin,
leupeptin, and phenylmethylsulfonyl fluoride). Total lysates
(500 to 1,000 pLI) were precleared with 5 plA of normal rabbit
serum for 30 min on ice, and then 80 RA of 50% protein
A-plus-protein G Sepharose beads (Oncogene Sciences) was
added. After removal of nonspecific immune complexes, either
4 to 6 jil of specific serum (1:100) or 5 jig of affinity-purified
antibody was added, and the mixture was incubated for 2 h at
4°C. Immune complexes were precipitated with 30 RI of
protein A-plus-protein G beads. After extensive washing, the
beads were resuspended in 30 pl of protein loading buffer,
boiled, and loaded onto SDS-polyacrylamide gels.
Western blot (immunoblot) analysis. Equal amounts of
protein lysates (5 jig of nuclear extract and 20 jig of cytosol,
equivalent to 106 cells per sample) from 70Z/3 and WEHI 231
cells were loaded onto each lane of several identical protein
gels. After transferral to nitrocellulose filters, the blots were
stained with Ponceau S to confirm the uniformity of protein
loading in each lane. Filters were then blocked with 2% nonfat
milk-TBST (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.05%
Tween 20) for 1 h and incubated with specific antibody at a
dilution of 1:1,000 in 2% nonfat milk-TBST for 2 h at room
temperature. After three washes with TBST, filters were
incubated with the secondary antibody (goat anti-rabbit IgG-
horseradish peroxidase conjugate) for 1 h, and antibody-
reactive bands were revealed by chemiluminescent detection
(ECL Western detection kit; Amersham International).
Transfection and luciferase assay. p50, p65, and Rel were
subcloned into a retroviral vectro, pGD (40). None or 0.2, 0.4,
or 0.6 jig of the p50, p65, and Rel expression constructs alone
or in combination was cotransfected with 1 jig of different
luciferase reporter constructs into L929 cells by the calcium
phosphate transfection method. The total amount of trans-
fected DNA was normalized to 0.6 jig in all transfections using
empty vector DNA. Both expression and luciferase constructs
were added to 100 jil of transfection solution (75 plA of 2x HBS
[8 g of NaCl, 0.105 g of Na2HPO4, and 6.5 g of HEPES in 500
ml], 9.3 jil of 2 M CaCl2), and the mixture was immediately
applied to each well of a 24-well plate. L929 cells were grown
to 50% confluency at the time of transfection. Transfections
were performed in triplicate. Two days posttransfection, the
cells were lysed and luciferase activity was measured by
luminometer (Promega luciferase assay system).
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FIG. 1. Components of nuclear NF-KB/Rel complexes and sensi-
tivities to IKB. Shown is EMSA of 70Z/3 and WEHI 231 nuclear
extracts with antibody inhibition. Purified specific antibodies (5 p5g) to
each NF-KB/Rel component were preincubated with nuclear extracts
prior to addition of a loop oligonucleotide probe containing an MHC
class I KB site (10). Nuclear extracts were prepared from cells treated
with PMA for 4 h. Equal amounts of nuclear extract (2.5 p.g) were
applied to each lane. CK represents control normal rabbit serum.
Positions of specific NF-KBIRel complexes (I through IV) are indi-
cated by arrows. Each complex was quantitated by a PhosphorImager
(Molecular Dynamics), and the percentage of residual binding was
determined (indicated below the lanes).
RESULTS
NF-KB/Rel complexes in two model cell lines. Sen and
Baltimore (42) originally observed constitutive NF-KB binding
activity in nuclear extracts of mature B-cell lines but saw no
such activity in extracts of pre-B-cell lines. NF-KB activity in
pre-B-cell lines, however, can be induced by LPS or PMA
treatment (41). To characterize the proteins involved in the
NF-KB activity of B-lineage cells, we examined the constitutive
and inducible NF-KB complexes in two cell lines representative
of pre-B and mature B stages, 70Z/3 and WEHI 231. Equal
amounts of nuclear extract protein prepared from uninduced
or induced 70Z or WEHI 231 cells were subjected to EMSA.
Pretreatment with purified antibody specific for individual
NF-KB/Rel members was used to identify the protein constit-
uents of the shifted complexes. Antibody specificities were
tested by using purified p50, p6as or Rel protein. Under our
experimental conditions, there was no cross-reactivity between
a given antibody and noncognate members of the NF-KB/Rel
protein family (not shown).
Since NF-KB/Rel heterodimers bind equally well to both IgK
and major histocompatibility complex (MHc) class I KB sites,
but p50 and p52 homodimers bind with higher affinity to the
class I site than to the Ig KB site (10, 31), we used the class I
KB site as the probe in most EMSAs described in this report.
As reported previously (41), uninduced 70Z/3 cells contained
little or no detectable nuclear NF-KB activity by EMSA (data
not shown), but a 4-h treatment with LPS orP1Ainduced the
nuclear appearance of NF-KB/Rel activity (Fig. 1). The PnA-
induced complex I was specifically inhibited by anti-p5O and
anti-p65 antibodies (decreased 100 and 85%, respectively) but
very little by other antibodies. Complex II was a p50 ho-
modimer because it was blocked by anti-p5O antibody only
(Fig. 1). Complex III was probably a degradation product of
p5O/p65 because its properties were like that of complex
Therefore, psO/p65 is the inducible complex in 70Z/3 cells. By
contrast and as expected (42)5,WEHI 231 expressed constitu-
tive nuclear NF-KB/Rel which was further stimulated by PMgA
or LPS. The constitutive and inducible NF-KB/Rel complex IV
in WEHI 231 cells was inhibited by both anti-p5O and anti-Rel
antibodies (decreased 100 and 88%, respectively) but not by
other antibodies (Fig. 1), indicating that a pSO/Rel dimer is the
predominant NF-KB/Rel complex in WEHI 231 cells, although
some p5O/p65 was present. Complex II had the properties of a
p5O homodimer. Thus, 70Z/3 and WEHI 231 cells contain
different NF-KB/Rel complexes: p5O/p65 is the major inducible
complex in 70Z/3 cells, and p5O/Rel is the major constitutive
and inducible complex in WEHI 231 cells. Both cell types had
a basal level of P502 that was not inducible upon stimulation
(data not shown).
The nuclear NF-KB/Rel complexes were then tested for their
susceptibility to inhibition by IKB-a. For this purpose, IKB-a
was purified as a fusion protein with glutathione S-transferase
(27). The inducible nuclear complex in 70Z/3 cells and the
constitutive complex in WEHI 231 cells were equally sensitive
to inhibition by IKB-a-glutathione S-transferase (data not
shown). Thus, there is no major qualitative difference in the
sensitivity to lKB-a inhibition between the constitutive and the
inducible nuclear NF-KB/Rel complexes in these two cell types.
Most cellular NF-KB/Rel in unactivated cells is stored in the
cytoplasm as a non-DNA-binding complex with IKB or an
IKB-containing precursor molecule like p105 (19, 36, 37). To
examine the inactive complexes in 70Z/3 and WEHI 231 cells,
we used immunoprecipitation analysis of 35S-radiolabeled ly-
sates with antibody against p65, Rel, or IKB-at. Under condi-
tions that allowed coimmunoprecipitation of associated pro-
teins, in 70Z/3 cells, IKB-a was coprecipitated with serum to
either p65 or Rel (Fig. 2A, lanes 2 and 3) (36). Both p65 and
Rel in 70Z/3 cells were also associated with the p105 precursor
(lanes 2 and 3). Interestingly, 70Z/3 cells contained not only
p65 but also a reasonable amount of cytoplasmic Rel (lane 3).
However, the Rel complexes in 70Z/3 cells seem to be less
responsive to stimulation by LPS or PMA in that they do not
appear in the nucleus (Fig. 1). A small portion of Rel may also
be associated with p65 (lane 3), as has been suggested previ-
ously (36).
There is a high level of expression of Rel protein in WEHI
231 cells. IKB-ao, p105, and p65 were associated with Rel (Fig.
2A, lane 7) (36). There is much less p65 protein than Rel
protein in the cytoplasm of WEHI 231 cells, and it is mainly
associated with IKB-a rather than p105 (lanes 6 and 7). The
IKB-a antibody coimmunoprecipitated lKB-a and Rel protein
(lane 8) but not with any of the precursor, p105 (lane 4), in
WEHI 231 cells. Therefore, IKB-a and p105 are mutually
exclusive, perhaps indicating that only one IKB-like molecule is
in complex with a dimer of NF-KB/Rel protein. In 70Z/3 cells,
IKB-a antibody failed to detect IKB-a protein, possibly because
of the low level of IKB-a in 70Z/3 cells. Alternatively, the
antibody may have low affinity for lKB-a protein in a complex
form.
Because p5O protein comigrates with the precipitating anti-
body, it has been difficult to quantitate the p5O protein by
immunoprecipitation. Therefore, to resolve p5O-containing
complexes, we used DOC treatment followed by EMSA to
examine the inactive NF-KB/Rel complexes in cytosol. The
DOC-released NF-KB/Rel complex was mainly p5O/Rel in
WEHI 231 cells and pSO/p65 in 70Z/3 cells (Fig. 2B). Thus,
there is a p5O/p65/IKB complex in the cytoplasm of 70Z/3 cells
and a p5O/RelIIKB complex in WEHI 231 cells, from which
IKBs are readily removed by detergent or by physiological
stimulation.
Expression level of NF-KB/Rel and IKB proteins in 70Z/3
and WEHI 231 cells. In addition to EMSA and immunopre-
cipitation, we performed Western blot analysis to investigate
the relative amounts of NF-KB/Rel and lKB proteins in these
two cell lines. The NF-KB/Rel components that translocated to
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FIG. 2. NF-KB/Rel components in the cytosolic fractions of 70Z/3
and WEHI 231 cells. (A) Coimmunoprecipitation of NF-KB/Rel and
IKB-a proteins in 70Z/3 and WEHI 231 cells. Cytosolic lysates from
35S-labeled 70Z/3 and WEHI 231 cells were immunoprecipitated with
normal rabbit serum (CK) or serum against p65, Rel, or IKB-a in an
NP-40-based buffer (see Materials and Methods) that allows coimmu-
noprecipitation of associated protein complexes. Specific protein
bands are marked with arrows. (B) DOC-released cytoplasmic com-
plex is p50/p65 in 70Z and pSO/Rel in WEHI 231 cells. Ten micrograms
of cytosolic proteins was treated with 0.8% DOC to release NF-KB/Rel
complexes from IKB-a, after which 1% NP-40 and specific antibody
were added to the EMSA reaction. The arrow indicates the NF-KB/Rel
complexes.
the nucleus after a 4-h LPS ou PMA induction were also
examined. To limit the study to immediate responses to
stimulation, de novo protein synthesis was blocked with cyclo-
heximide. Equal amounts of lysate protein were analyzed in
each lane (5 ,ug from nuclei and 20 jig from cytosol, equivalent
to 106 cells per lane).
From several gels probed with antibody specific to NF-KB
and IKB proteins, it was evident that WEHI 231 cells had 3- to
10-fold-higher levels of p50, Rel, IKB-a, Bcl-3, and p105 than
did 70Z/3 cells (Fig. 3). p65 protein was twofold less in WEHI
231 than in 70Z/3 cells (Fig. 3B). There was a continuous
degradation (and therefore resynthesis) of p65, Rel, IKB-a,
and p105 in WEHI 231 cells because a 4-h cycloheximide
treatment reduced the levels of these proteins (Fig. 3B, C, D,
and G). About 30% of total cellular p5O and 20% of the Rel
proteins was in the nuclear extract of uninduced WEHI 231
cells, but none was found in 70Z/3 nuclei (Fig. 3A and C). The
nuclear p50 and Rel made up the preponderance of the
constitutive NF-KB/Rel activity, as detected by EMSA in
WEHI 231 nuclei (Fig. 1A). Upon induction, 50 to 60% of
total p5O and Rel proteins were found in WEHI 231 nuclei
(Fig. 3A and C), demonstrating induced translocation of these
proteins. The same stimuli also caused nuclear translocation of
30 to 40% of total p5O and 35 to 55% of p65 protein in 70Z/3
cells (Fig. 3A and B).
With respect to the NF-KB-bound proteins, there was a
discernible level of IKB-a in WEHI 231 cells but little in 70Z/3
cells (Fig. 3D). Thus, the constitutive nuclear NF-KB/Rel
activity in WEHI 231 cells could not be attributed to reduced
IKB-a expression. Bcl-3 in WEHI 231 cells was sevenfold
higher in the cytosol than in the nuclei (Fig. 3E), and induction
with LPS and PMA caused little or no increase in the nuclear
concentration. 70Z/3 cells did not have detectable Bcl-3. IKB--y
and p105 were present exclusively in the cytosolic fraction (Fig.
3F and G). The level of IKB--y was slightly higher in 70Z/3 cells
than in WEHI 231 cells, consistent with the higher expression
level of IKB--y mRNA in 70Z/3 cells (20, 26). Interestingly, LPS
but not PMA treatment of both 70Z/3 and WEHI 231 cells led
to loss of the p105 precursor (Fig. 3G).
To characterize the kinetics of p105 processing, WEHI 231
cells were induced at various time periods by either LPS or
PMA. Equal amounts of lysate were resolved by SDS-poly-
acrylamide gel electrophoresis and subjected to Western blot
analysis using anti-p5O antibody. LPS induction causes in-
creased processing of p105, whereas PMA did not (Fig. 3H).
The induced processing became obvious after 1 h of LPS
treatment (decreased 45%) and further enhanced after 4 h of
stimulation (decreased 65%). Other stimuli, such as anti-IgM
and TNF-a, like PMA, did not cause p105 processing in WEHI
231 cells (data not shown). These results suggest that various
stimuli trigger different regulatory pathways for the activation
of NF-KB/Rel protein.
IKB-a protein turns over rapidly in WEHI 231 cells. IKB-a
is rapidly degraded following stimulation with a variety of
agents (5, 18). Free IKB-at is degraded within about 30 min,
whereas it is stable for longer than 6 h when complexed with
p65 (40). Since there is continuous synthesis of IKB-a in WEHI
231 cells (Fig. 3D), there must be a continuous turnover
maintaining a dynamic balance of IKB-a in these cells. To test
this interpretation, we measured the turnover of IKB-a in both
70Z/3 and WEHI 231 cells by pulse-chase experiments (Fig. 4).
Cells were labeled with [35S]methionine for 2 h and chased
with cold medium for various times. Lysates were immunopre-
cipitated with anti-IKB-a antibody, and the 35S-labeled protein
bands corresponding to IKB-a from each time point were
quantitated. IKB-ao in WEHI 231 cells had a much faster and
more extensive degradation than in 70Z/3 cells (Fig. 4). The
fast turnover of IKB-a protein may be partly responsible for
the constitutive nuclear pSO/Rel and p5O/p65 in WEHI 231
cells.
Modification by phosphorylation has been suggested as one
of the regulatory mechanisms of NF-KB activation in vitro (12).
We therefore tested if phosphorylation of endogenous NF-KB/
Rel or IKB proteins in 70Z/3 and WEHI 231 cells might
account for the constitutive nuclear NF-KB/Rel activity in
WEHI 231 cells. Results from phosphopeptide analyses indi-
cated that both the basal and inducible phosphorylation pat-
terns of p65, Rel, and IKB-ao were comparable in these two
cells (data not shown). Therefore, the constitutive nuclear
component of NF-KB/Rel in WEHI 231 cells is not a conse-
quence of a readily discernible difference in basal protein
phosphorylation between these cells and 70Z cells.
Sequential expression of various NF-cB/Rel complexes in
B-lineage cells. The presence of two different predominant
complexes in two B-lineage cell lines prompted us to examine
other B-cell lines of various differentiation stages. M12 is a
B-cell lymphoma derived from BALB/c mice that was adapted
to in vitro culture. These cells synthesize IgG2a in both a
secreted and a membrane form. P3X63Ag (termed XAg here)
is derived from the MOPC-21 myeloma and secretes IgGl.
S194, S107, and J558L were derived from IgA-producing
plasmacytomas and thus represent the terminal differentiation
stage of B cells.
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FIG. 3. Western blot analyses of lysates prepared from 70Z/3 and WEHI 231 cells induced with LPS or PMA. 70Z/3 and WEHI 231 cells were
untreated (-) or treated for 4 h with cycloheximide (C; 10 ,ug/ml), LPS (10 pug/ml), or PMA (100 nM). Each protein blot was incubated with serum
specific to p5O (A, F, G, and H), p65 (B), Rel (C), IKB-a (D), or Bcl-3 (E). For panel H, WEHI 231 cells were treated with either LPS (10 ,ug/ml)
or PMA (100 nM) and analyzed by Western blot analysis with the anti-pSO serum. Arrows indicate specific p105 protein bands. The intensity of
each protein bands was quantitated by densitometer and represented as relative optical density (O.D.) value.
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FIG. 4. IKB-a has a faster turnover rate in WEHI 231 than 70Z/3
cells. 70Z/3 and WEHI 231 cells were labeled for 2 h with [35S]methi-
onine and chased with cold medium for 0, 10, 20, 40, 60, 120, 300, and
960 min prior to immunoprecipitation with serum against IKB-aL.
Amounts of labeled IKB-a at each time point were determined by
Phospholmager analysis of SDS-polyacrylamide gels of immunopre-
cipitates and expressed as a percentage of the initial IKB-a counts per
minute at time zero.
We first examined whether these cell lines express constitu-
tive NF-KB activity. The constitutive low-level NF-KB/Rel
complexes in nuclei from uninduced B-cell lines were three- to
fivefold higher than in 3T3 fibroblasts (Fig. SA). Most mature
B-cell lines and plasmacytomas tested contained constitutive
NF-KB/Rel complexes in their nuclear fractions (data not
shown). LPS or PMA stimulation of B-cell lines and splenic B
cells increased the nuclear level of NF-KB/Rel complexes (Fig.
5A). The composition of each complex was analyzed by
inhibition with specific antibody, using higher-resolution
EMSA. The complexes in two mature B cells, XAg and M12,
were inhibited or supershifted by antibody for p50, p65, and
Rel (Fig. SB), suggesting that they consist of pSO/p65, pSO/Rel,
or p65/Rel complexes.
When plasmacytomas S194, S107, and J558L were analyzed
by EMSA, the complex pattern was very different from that of
pre-B- or mature B-cell lines described above. Nuclear extracts
of untreated (data not shown) or LPS-induced S107 and J558L
revealed four complexes: complex I, composed of p50, p52,
and RelB; complex II, consisting of p52 and Rel; complex III,
with p50, p65, and Rel; and complex IV, a p50 homodimer
(Fig. 5C). LPS-induced S194 had a unique pattern in which
complex V was p50 and p65, complex VI only showed RelB,
and complex IV was P502 (Fig. 5C). Therefore, all plasmacy-
tomas expressed RelB-containing complexes either constitu-
tively or upon induction. Two of the three plasmacytomas
tested also expressed p52-containing complexes. p52 and RelB
may thus be expressed at the latest stage of B-cell differenti-
ation, in contrast to p50, p65, and Rel, which are expressed at
an intermediate stage, and p50 and p65, which predominate in
the pre-B-cell stage.
LPS is a potent B-cell mitogen capable over days of promot-
ing B-cell differentiation in vitro. To test whether expression of
p52 and RelB proteins would be induced, we analyzed nuclear
extracts obtained from 70Z/3 pre-B- and M12 B-cell lines that
were treated with LPS for 3 days. LPS treatment caused the
cells to differentiate into lymphoblasts with a dramatic increase
in cell volume. The binding pattern of their nuclear extracts
consisted of the same four complexes found in plasmacytomas
(Fig. SC and D). These results suggest that the NF-KB/Rel
proteins are induced sequentially during B-cell maturation to
plasma cells.
The foregoing data relate to continuously growing cell lines,
but B cells are mainly resting cells in lymphoid organs. To
analyze which NF-KB/Rel complexes might exist in vivo, we
isolated resting splenic B cells by Percoll gradient fractionation
following Thy 1 antibody lysis ofT cells. Purified resting splenic
B cells express a constitutive low level of NF-KB/Rel complexes
that was fivefold higher than in 3T3 fibroblasts (Fig. SA). LPS,
PMA, and anti-IgM were capable of further inducing nuclear
translocation of NF-KB/Rel complexes in resting splenic B cells
(Fig. 5A and data not shown). Nuclear extracts prepared from
two batches of splenic B cells treated with anti-IgM were
analyzed by antibody treatment and EMSA (Fig. 5E). Complex
I in both extracts contained p50, p65, and Rel, as indicated by
specific antibody inhibition. Complexes II and III contained
p50 and RelB and were detected in only one of four prepara-
tions of spleen extract. It was reported that crude spleen
extract contains predominantly p50 and RelB (25). We believe
that the RelB content may result from plasma cells or other
previously activated cells and may be inconsistent because of
the variable health histories and ages of animals.
In summary, we detected various NF-KB/Rel complexes that
were differentially expressed in both splenic and B-lineage cells
by EMSA and antibody supershift analysis (Table 1). In pre-B
cells as in nonlymphoid cells, NF-KB pSO/p65 is the major
inducible complex that appears in the nucleus. Mature B cells
constitutively express p50, p65, and Rel complexes in the
nucleus. Terminally differentiated plasmacytoma and long-
term LPS-treated pre-B- and B-cell lines further express p52-
and RelB-containing complexes in addition to the p50-, p65-,
and Rel-containing complexes. Finally, splenic B cells contain
complexes composed of p50, p65, Rel, and, occasionally, RelB.
Differential target gene specificities of various NF-KB/Rel
complexes. We have shown that multiple NF-KB/Rel com-
plexes are expressed in B cells at various differentiation stages.
To examine whether the variety of NF-KB/Rel complexes could
carry out distinct functions at different stages of development,
we tested the transcription activities of different NF-KB/Rel
complexes by transient transfection assay. Several luciferase
reporter plasmids that contain luciferase cDNA under the
control of divergent KB sites derived from either the IgK,
IFN-P, IL-2R, or Myc regulatory sequences were constructed.
Expression constructs containing p50, p65, and c-Rel cDNAs
in the same vector backbone, either singly or in combination,
were cotransfected with each individual luciferase reporter
plasmid into the L929 fibroblast line. The expression levels of
all constructs were comparable, as tested by Western blot
analysis and EMSA (data not shown). The various NF-KB/Rel
complexes did demonstrate individual patterns of response on
different target sites under the same transfection conditions, as
might have been predicted (10). In particular, the pSO/p65
heterodimer was the best transcriptional activator of the
canonical Ig KB site (Fig. 6). Both p50 and p65 contribute in
the transactivation of the Ig KB site because neither ho-
modimer was as good as the heterodimer, although p65 was
quite effective on its own. In contrast, all complexes, except the
p50 homodimer, failed to transactivate through the IL-2R KB
site (Fig. 6). The transcriptional activity of p50 on the IL-2R
KB site was comparable to its activity on the IgK and IFN-,
sites. Intriguingly, p65 homodimer strongly activated transcrip-
tion through both the IFN-P and Myc KB sites but not the
IL-2R site. Rel synergized with p65 in the activation of the
IFN-, KB site. Overall, Rel itself was a weak transcription
activator on the selected KB sites studied. The optimal KB sites
for Rel are yet to be identified. The results suggest that various
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FIG. 5. NF-KB/Rel components are differentially expressed in B cells of various stages of differentiation. (A) Constitutive NF-KB/Rel activity
in B-cell lines and splenic B cells. Shown is an EMSA of 5 jig of nuclear extracts from various cells; + indicates treatment of cells with TNIF-cx
(3T3 cells), anti-IgM (resting B cells), or PMA (XAg and S194 cells). (B) Mature B cells express p50, p65, and Rel in the nucleus. Shown is an
EMSA of nuclear extracts from XAg and M12 cell lines that were induced with PMIA for 4 h. The NF-KcB/Rel components in each complex were
assessed by antibody inhibition as described for Fig. 1A. Percentage of residual binding was quantitated by a PhosphoImager. (C) S194, S107, and
J558L plasmacytoma cells contain additional p52 and RelB complexes. Shown is an EMSA of nuclear extracts from S194, S107, and J558L
plasmacytoma cells treated with PMlA for 4 h. The S107 line used in this study is a different subline from that described by Atchison and Perry
(2), which lacks NF-KcB. (D) Long-term LPS stimulation of 70Z/3 and M12 cells leads to the induction of p52 and RelB complexes. Shown is an
EMSA of nuclear extracts from 70Z/3 and M12 cells cultured in the presence of LPS (10 j±g/ml) for 3 days (3d). (E) NIF-KB/Rel components in
two preparations of resting splenic B cells. Shown is an EMSA of nuclear extracts from two preparations of resting splenic B cells stimulated with
anti-IgM for 4 h.
NF-KB/Rel components can regulate distinct sets of target
genes during B-cell activation, although the particular re-
sponses seen in this experiment were a consequence both of
the products of the transfected genes and of endogenous
complexes that they may induce.
DISCUSSION
Originally, NF-KB was defined as an activity that shifted the
mobility of a DNA probe containing a KB site. Later, the
subunit composition of latent NF-KB in unactivated cells was
found to be p50 and p65. When these subunits were shown to
be related to Rel, other members of the NF-KB/Rel family
were identified, and the composition of NF-KB in various cell
types became an issue. Here we have examined the composi-
tion of NF-KB in cells of the B-lymphocyte lineage and have
found that it changes in a developmentally ordered fashion. In
pre-B cells, typified by 70Z/3 cells, cytoplasmic, IKB-bound
p5O/p65 is the predominant form, with a minor fraction of
C S194 SI107 J558
VOL. 14, 1994
N binding) 0 en 0 N cn 0 Ln0 w- 0 Ln W 0 V--
r', r, r,
5356 LIOU ET AL.
TABLE 1. Summary of nuclear NF-KB/Rel components
EMSA resulta
Complex 3T3 Spleen B 7( Z/3 WEHI 231 M12, XAg S194 S107,J558L 70Z M12
(TNF-oL) (IgM, 4 h) (LPS, 4 h) WH 3 1,Xg S9 17 58 (LPS, 3 days) (LPS, 3 days)
p50 + + + + + + + + +
p65 + + + Low + + + + +
Rel - + Low + + - + + +
p52 - _ +
RelB - Low - - - + + + +
a The nuclear DNA-binding complexes of NF-KB/Rel proteins in various cell types were assessed by inhibition with a specific antiserum followed by EMSA. +, a
detectable level of the tested NF-KB/Rel component was found with the specific antibody; -, the component was undetectable in the nuclear extract by the specific
antibody under the described experimental conditions; low, a barely detectable level of the protein was found.
p5O/Rel bound to IKB. In mature B-lymphoid cells, typified by
WEHI 231 cells, p5O/Rel predominates. B cells have constitu-
tive, nuclear NF-KB that is sensitive to the inhibitor, IKB-cU; its
constitutivity seems to be related to a fast turnover of IKB-ct,
not to a lack of synthesis of the inhibitor. Terminally differen-
tiated B cells, represented by plasmacytomas, have NF-KB
complexes involving p52 and RelB. Splenic B cells, which are a
mixed population, have largely p5O/p65 and pSO/Rel com-
plexes. NF-KB/Rel factors of different subunit compositions
differentially activate transcription, depending on the particu-
lar sequence of the KB site in a reporter construct. The shift in
NF-KB/Rel composition during B-cell differentiation may play
a role in lineage-specific gene regulation.
Differential expression of NF-KB/Rel proteins in B-lineage
cells. One of the most intriguing observations is the differential
expression of various NF-KB/Rel complexes in B cells of
different developmental stages. p5O/p65 is the major inducible
complex in pre-B cells; p5O/Rel appears at the mature B-cell
stage; p52 and RelB occur late in plasma cells. The sequential
appearance of NF-KB/Rel components suggests a sequential
programming of their synthesis. Since the differentiation pro-
cess in B cells can be induced by long-term stimulation with
LPS, we tested whether the expression of p52 and RelB in
plasma cell lines could be reproduced by mimicking the
differentiation process in vitro with LPS treatment of two
earlier-lineage B-cell lines derived by different transformation
methods. Interestingly, both a pre-B- and mature B-cell line
treated with LPS for several days began to utilize p52 and RelB
in induced complexes. The induction of p52 and RelB com-
plexes in these cell lines by LPS treatment is unlikely to result
solely from the nuclear translocation of NF-KB activity, since
mature B cells already have constitutive nuclear p5O and Rel
proteins yet do not usually express high levels of p52 and RelB.
The differential target gene specificity of each NF-KB/Rel
component suggests that the ordered expression of each
member of the NF-KB/Rel protein family during B-cell devel-
opment may be to help regulate genes that are involved in
stage-specific function. c-Rel is made primarily in lymphoid
tissues, and oncogenic v-Rel is associated with B-cell lym-
phoma, suggesting that Rel protein may participate in cell
cycle control in mature B cells. p52 and RelB are expressed
predominantly in plasma cells. Different NF-KB/Rel complexes
bind with variable affinity to different KB target sequences.
Also, although p5O homodimer binds equally well to the IgK,
MHC class I, and IFN-,B KB sites, it transactivates expression
only from the MHC class I site (10). This is due to a
conformational change in p5O when binding to the MHC class
I site. p52/p65 had the capacity to bind to various KB sites, but
it failed to activate reporter constructs with either H2 or IL-2R
KB sites (6, 34, 39). Therefore, both binding affinity and
conformation may determine whether a NF-KB/Rel complex
can activate transcription from a particular KB site. Studies on
p52 and RelB suggest that they also have unique recognition
and transcription properties for divergent KB sites that are
distinct from other NF-KB/Rel members (6, 38). p52 and RelB
were able to synergize with each other in the activation of
reporter construct with Ig KB site (6, 38). Deregulation of plOO
that leads to changes in the nuclear localization and transcrip-
tional properties of the p52 gene seems to correlate with its
oncogenicity in B cells, suggesting that tight regulation of p52
may also be important to maintain B cells at their steady state.
The full expression of five members of the NF-KB/Rel mem-
bers at the terminal differentiation stage of B cells has the
potential to regulate many genes.
NF-KB may not have a developmental role. Previous data
have suggested that NF-KB has two roles: in mature cells, it
acts as a rapid response transcriptional activator; in developing
cells, particularly B-lineage cells, it is a determinant of pre-B
cell differentiation. The present data bring an aspect of that
perspective into question. The rapid response properties of its
activity are strongly supported: pSO/p65 is clearly a cytoplas-
mically stored gene activator awaiting a signal to move to the
nucleus, bind to DNA, and initiate an activation cascade of
Rel-related proteins. The evidence for NF-KB involvement in
pre-B-cell differentiation was largely that it was found in the
cytoplasm of pre-B cells and constitutively in the nuclei of
B-lymphoid cell lines, like WEHI 231. However, if the impetus
to grow in these cells, which presumably comes from onco-
genes that are active in them, is equivalent to an activation
stimulus, then their properties may not relate to their differ-
entiation state but only to their activation state. Very recently,
we have created a mouse with a null mutation in the NFKB-
l(p50) gene, and it can make surface-IgpLK-positive B cells in
normal amounts (43). This finding suggests that p50 at least
may not play a role in differentiation events that lead to mature
B cells.
One way to determine whether the constitutive NF-KB in
B-cell lines is an indicator of their differentiation state or their
activation state would seem to be to examine resting splenic B
cells. The literature, however, suggests that B cells either have
(28) or do not have (29) endogenously active NF-KB. We
reexamined this question by purifying resting B cells by using
Percoll gradients (8). They show a low level of nuclear NF-KB,
more than 3T3 cells and less than B-cell lines. They also can be
induced to translocate more NF-KB to their nuclei; this is a
mixture of p5O/p65 and p5O/Rel. The cells purified from
Percoll gradients, though, should be a mixture of memory B
cells and virgin B cells, with perhaps other cell types included.
Therefore, the definitive answer to the question of whether
resting virgin splenic B cells express constitutive NF-KB activity
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awaits a more detailed study of defined subpopulations of cells,
which was beyond the scope of this investigation. Klug et al.
(23) recently reported the detection of a constitutive NF-KB
activity in IL-7-expanded pre-B cells from the Whitlock-Witte
bone marrow culture system. The constitutive activation of
NF-KB in the nucleus of pre-B cells may reflect a natural
differentiation process through interaction with stromal cells in
bone marrow or result from an activation process due to the
presence of IL-7 in the in vitro differentiation system.
In our studies, both crude and purified resting spleen B-cell
extracts are mainly composed of p50, p65, and Rel, the same
components also observed in mature B-cell lines. One of four
tested splenic B-cell preparations also expressed RelB (Fig.
p50 p50 p65 5E). This is in contrast to the consistent observation by
p65 Rea Rel Lernbecher et al. (25) of p50/RelB in crude spleen B cells. Not
only might the health status of their mice cause this result, as
suggested by our occasional similar observation, but also their
inclusion of activated splenic cells in their preparations might
be a factor because we excluded such cells by use of Percoll
gradient purification.
The activation process. The cytoplasmic NF-KB complexes
with IKB can be dissociated and NF-KB can rapidly be trans-
located to the nucleus by an activation stimulus. Activation is
caused by cell-specific mediators such as TNF-a, antigens,
LPS, PMA, and IL-1. The mechanism of release of NF-KB
from lKB is controversial and may involve multiple pathways;
both phosphorylation of IKB and its degradation appear to play
p50 p50 p65 roles in activation. Whatever the events that ensue from an
+ + + activation stimulus, it leads to loss of detectable IKB which is
then resynthesized (5). If the activation signal is transient, the
new lKB can capture the existing NF-KB and return it to the
cytoplasm (5, 36, 40, 44). If the activation process continues, a
steady state of synthesis and degradation of IKB is established
in an activated cell (Fig. 3) (36). The movement of NF-KB to
the nucleus in an activated cell leads to increased transcription
of genes with KB regulatory sites. Among such genes are
IKB-a, Rel, and p105, all of which are transcribed more
extensively after activation (16, 17, 30). Thus, even though
IKB-a is degraded very rapidly in activated cells, it is made at
a higher rate than in unactivated cells.
The properties of WEHI 231 cells are therefore those of
p50 p50 p65 chronically activated cells. They have a high level of IKB-a that
+ + + turns over rapidly and a high expression of Rel. The oncogenesp65 Roel Rel active in WEHI 231 cells are not known, but they could give
rise to a chronically activated state. What causes the constitu-
tive NF-KB activity in WEHI 231 B cells? Since WEHI 231
cells express high levels of IKB-a, IKB--y, and Bcl-3, the
possibility that IKB proteins are not expressed in WEHI 231
cells is ruled out. There is no major qualitative difference
between the inducible complex in 70Z/3 cells and the consti-
tutive complex in WEHI 231 cells because both are sensitive to
inhibition by 1KB-a, although it remains possible that p5O/p65
and p50/Rel complexes have different affinities for IKB. The
basal and stimulated phosphorylation statuses of IKB-a, p65,
and Rel proteins are comparable in these two cell types,
p50 p50 p65 suggesting that there is no major difference in the activities ofp+5 + 4. protein kinases. Several parameters may be related to the
p65 Rtel Rel constitutive p5O and Rel activities in WEHI 231 cells. One of
the striking results is that IKB-a turns over rapidly in WEHI
/Rel components demon- 231 cells. However, the mechanism responsible for IKB-a
ivexregssion cnnstneriqtc degradation remains to be identified. WEHI 231 cells expressML %JA%19,IIL %,IVlSllSCXlItUlla V1, F}Jv. FvJ) atllu xxv-i v%iWAM31hVIl %,VlOLlUf.La LV
differentially activate luciferase reporter constructs containing dimer-
ized KB sites corresponding to Ig K (GGGACT7JlCC), IL-2R (GG
GAATCTCC), Myc (GGGlTTTCCC), and IFN-P (GGGAAAT
TCC) sites were determined. Luciferase activity is shown as fold
induction over transfections with vector alone. All transfections were
done in triplicate for several dosages of expression constructs. ([l, 0
,ug; 0, 0.2 gLg; 0, 0.4 ,ug; and U, 0.6 gig).
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a lower level of IKB-y protein than 70Z/3 cells do. The 2.6-kb
spliced mRNA variant corresponding to IKB--y is expressed at
a higher level in pre-B-cell lines than in mature B cells (12, 27).
Such a differentiation-mediated down-regulation of the IKB--y
mRNA may be relevant to the nuclear translocation of p5O
homodimer. In addition, the high expression of Bcl-3 protein
in WEHI 231 cells may facilitate nuclear transport of p5O;
Bcl-3 as a coactivator of p5O may in turn enhance the tran-
scription of target genes through its interaction with p5O (11).
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